Geratherm Medical Dividends and Buybacks

Dividend criteria checks 1/6

Geratherm Medical is a dividend paying company with a current yield of 2.92%.

Key information

2.9%

Dividend yield

0.5%

Buyback Yield

Total Shareholder Yield3.5%
Future Dividend Yield1.5%
Dividend Growth-1.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per share€0.100
Payout ratio-65%

Recent dividend and buyback updates

Geratherm Medical (ETR:GME) Is Reducing Its Dividend To €0.12

Apr 10
Geratherm Medical (ETR:GME) Is Reducing Its Dividend To €0.12

Recent updates

Geratherm Medical AG (ETR:GME) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Dec 13
Geratherm Medical AG (ETR:GME) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Investors Don't See Light At End Of Geratherm Medical AG's (ETR:GME) Tunnel And Push Stock Down 26%

Oct 16
Investors Don't See Light At End Of Geratherm Medical AG's (ETR:GME) Tunnel And Push Stock Down 26%

The Market Lifts Geratherm Medical AG (ETR:GME) Shares 28% But It Can Do More

Aug 21
The Market Lifts Geratherm Medical AG (ETR:GME) Shares 28% But It Can Do More

We Think Geratherm Medical's (ETR:GME) Solid Earnings Are Understated

Jun 27
We Think Geratherm Medical's (ETR:GME) Solid Earnings Are Understated

Geratherm Medical (ETR:GME) Is Reducing Its Dividend To €0.12

Apr 10
Geratherm Medical (ETR:GME) Is Reducing Its Dividend To €0.12

Is Geratherm Medical (ETR:GME) A Risky Investment?

Mar 02
Is Geratherm Medical (ETR:GME) A Risky Investment?

Geratherm Medical (ETR:GME) Has Some Way To Go To Become A Multi-Bagger

May 08
Geratherm Medical (ETR:GME) Has Some Way To Go To Become A Multi-Bagger

Is Geratherm Medical AG's (ETR:GME) 2.1% Dividend Sustainable?

Apr 19
Is Geratherm Medical AG's (ETR:GME) 2.1% Dividend Sustainable?

Is Geratherm Medical (ETR:GME) A Risky Investment?

Mar 01
Is Geratherm Medical (ETR:GME) A Risky Investment?

Returns On Capital Tell Us A Lot About Geratherm Medical (ETR:GME)

Jan 22
Returns On Capital Tell Us A Lot About Geratherm Medical (ETR:GME)

Consider This Before Buying Geratherm Medical AG (ETR:GME) For The 2.3% Dividend

Jan 04
Consider This Before Buying Geratherm Medical AG (ETR:GME) For The 2.3% Dividend

Update: Geratherm Medical (ETR:GME) Stock Gained 22% In The Last Year

Dec 17
Update: Geratherm Medical (ETR:GME) Stock Gained 22% In The Last Year

We Think Geratherm Medical (ETR:GME) Can Stay On Top Of Its Debt

Nov 29
We Think Geratherm Medical (ETR:GME) Can Stay On Top Of Its Debt

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: GME's dividend payments have been volatile in the past 10 years.

Growing Dividend: GME's dividend payments have fallen over the past 10 years.


Dividend Yield vs Market

Geratherm Medical Dividend Yield vs Market
How does GME dividend yield compare to the market?
SegmentDividend Yield
Company (GME)2.9%
Market Bottom 25% (DE)1.7%
Market Top 25% (DE)4.9%
Industry Average (Medical Equipment)1.8%
Analyst forecast (GME) (up to 3 years)1.5%

Notable Dividend: GME's dividend (2.92%) is higher than the bottom 25% of dividend payers in the German market (1.72%).

High Dividend: GME's dividend (2.92%) is low compared to the top 25% of dividend payers in the German market (4.91%).


Earnings Payout to Shareholders

Earnings Coverage: GME is paying a dividend but the company is unprofitable.


Cash Payout to Shareholders

Cash Flow Coverage: GME is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 15:47
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Geratherm Medical AG is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Oliver Wojahnmwb research AG
IGOR KIMOddo Seydler
Enid OmerovicOddo Seydler